€500m EU Research Pot: Which Irish Companies Actually Got Funded, and How to Apply Next Round
Ireland takes roughly 1.3% of Horizon Europe's total budget. Our population is 1% of the EU. On paper, that sounds fine. In practice, it means Irish firms are collecting scraps while German Mittelstand companies and Dutch university spin-outs are walking away with the main course.
Horizon Europe is the EU's flagship research and innovation programme running from 2021 to 2027, with a total budget of €95.5 billion. That is not an abstraction. Spread across seven years, it works out at roughly €37,000 being allocated every single minute across the bloc. Ireland's share of that, if we punched at our actual economic weight rather than just our population weight, should be closer to 2.5% given the size of our research base and the density of our tech sector. The gap between where we are and where we could be represents hundreds of millions in foregone non-dilutive capital.
Non-dilutive matters here. This is a grant, not equity. You do not give up a share of your company to access it. For an Irish founder choosing between a VC term sheet with painful clauses and a Horizon grant that funds two years of R&D, the grant wins every time, provided you know how to get it.
Who Is Actually Winning
The Irish companies and institutions pulling meaningful Horizon Europe money share three characteristics. They are working in sectors the EU has explicitly named as strategic priorities: health, climate, digital, and advanced manufacturing. They are applying as part of a consortium rather than alone. And they have a track record of managing public funding without making a mess of it.
Trinity College Dublin, University College Cork, and University of Galway are consistent anchor players, often bringing Irish SMEs into consortia as industry partners. This is the route most Irish companies miss entirely. They look at Horizon Europe, see a 200-page call document, and conclude it is only for universities. It is not. Industry partners in a consortium can draw down substantial portions of a project budget, sometimes 40% or more of the total, while the academic lead handles the bureaucratic heavy lifting.
In the health space, Irish medtech and digital health firms have been among the stronger performers. The EIC Accelerator, which is Horizon Europe's dedicated instrument for high-growth startups, has funded Irish companies working on diagnostics, remote monitoring, and surgical tools. The EIC does not fund incremental product tweaks. It funds things that either cannot get private funding yet because the technology is too early, or things that are too ambitious for a single national funding body. If your product fits that description, the EIC is worth the application cost.
Irish research spin-outs have been creating jobs at a rate that surprises even the people tracking them, and many of the better-performing ones have Horizon funding in their capital stack alongside Enterprise Ireland and SFI money. The pattern is consistent: EU funding goes to teams that treat grant applications as a core business activity, not an annual distraction.
Why Irish Firms Are Under-Represented
There are two reasons, and neither of them is that Irish companies are not innovative enough.
The first is consortium assembly. Horizon Europe favours applications involving multiple EU member states and a mix of academic and industry partners. Building that consortium takes time, relationship capital, and a willingness to share credit. Irish companies, particularly founder-led SMEs, are not set up for this. They are set up to move fast, not to spend nine months negotiating a partnership agreement with a university in Ljubljana.
The second is the proposal itself. A winning Horizon proposal is not a pitch deck. It is a structured argument across a mandatory template that runs to sixty pages or more, scored by independent evaluators against criteria that reward very specific language and very specific evidence of impact at EU level. Most Irish companies write these proposals the way they write investor decks: punchy, vision-led, light on methodology. The evaluators score them accordingly.
Both problems are solvable. Neither requires waiting for government to fix something.
The Four-Step Process to a Fundable Application
The order here matters. Skip step one and every subsequent step is harder.
Step 1: Pick the right call, not the most exciting one. The Horizon Europe work programme publishes calls a year or more in advance. Your job is to find the call where the EU's stated problem matches something you are already solving, not something you could theoretically solve if funded. Evaluators can tell the difference in two paragraphs. The CORDIS database lists every open and upcoming call. Start there, not with a broker selling you a shortlist.
Step 2: Join or build a consortium before you write a word. Horizon favours consortia of three to five partners across at least three EU member states. Enterprise Ireland's EU Funding team runs a partnership brokerage service specifically for this. Use it. Your consortium partners are not just there to tick a geographic box. They provide complementary capacity that your evaluator needs to believe your project will actually be delivered.
Step 3: Write the impact section as if the technology section does not exist. Irish applicants almost universally over-invest in describing what they are building and under-invest in describing what changes in Europe if it works. Horizon Europe is not funding products. It is funding outcomes. The evaluator's score sheet weights impact heavily. Write the impact section first, then make the technology section earn its place by explaining how it delivers that impact.
Step 4: Get an external review before you submit. Not from your accountant and not from a friend in tech. Find someone who has sat on a Horizon evaluation panel or who has managed a funded project. They will find the gaps in your methodology section that you have stopped seeing because you have read it thirty times. The Irish Research Council and SFI both have contacts who can point you toward qualified reviewers.
The Window Is Open
The 2025 to 2027 work programme calls are running now. The EIC Accelerator has two cut-off dates per year. The collaborative research calls under Horizon's main pillars close on rolling deadlines that are published twelve months in advance. There is no shortage of opportunity. There is a shortage of Irish companies treating this as a serious route to capital rather than a long-shot worth a weekend of effort.
The entrepreneur's choice here is simple: spend six months building a fundable consortium and proposal, or spend six months on the VC circuit giving away equity to fund the same R&D. Both are legitimate. Only one of them leaves you owning more of your company at the end.
Ireland's broader innovation ecosystem is evolving fast, but the companies benefiting most are not waiting for the ecosystem to deliver funding to their door. They are going to Brussels and making the case themselves.
Ireland has the research talent, the tech base, and the EU membership that makes Horizon access straightforward in principle. What is missing is the discipline to treat the application process as a skill worth building rather than a form worth filling.
Build the skill. The €500 million is not a pot. It is a queue. Get in it.